The Cardiovascular Molecular Imaging Program (CMIP) is a broad-based translational
and clinical molecular imaging effort that aims to better understand the molecular basis of
cardiovascular disease. An important focus of this work is to translate promising molecular
imaging agents into the clinical arena to better diagnose, risk stratify, and treat human
cardiovascular disease. We are actively utilizing an array of imaging readouts including
optical imaging (specifically near infrared fluorescence), magnetic resonance imaging,
integrated SPECT/CT imaging, optical coherence tomography and other intravascular imaging
techniques. We are closely involved with molecular imaging chemistry efforts, the mouse imaging
program, and the cellular imaging program at CMIR.